weight loss

Below is a summary of the topics we covered on Nucleus Investment Insights this month. See the links for more information.

In early March, Novo Nordisk held its Capital Markets Day which we attended virtually. Quite unusually, the day kicked off with the CEO interviewing a former obesity...

Breakthroughs in obesity drugs look extraordinarily profitable for 2 stocks. But, with improvements, a raft of sectors might be affected.

In a society riddled with low self-esteem and mental health issues, weight loss can be a controversial and difficult topic. Pop culture and social media do more harm...